There was, for instance, an effort that was initiated through a Parkinson's alliance two years ago, where several researchers, two in Ottawa and then team members elsewhere, tried to put forward an application for a national centre of excellence. This would have actually been a major milestone event to make teams collaborate and share data as soon as it becomes available and not wait for the year two until it's publicized or published in the literature. So this was an opportunity that couldn't be utilized. Essentially the application was denied: (a) there was not enough funding there, and (b), it wasn't felt that PD, Parkinson's disease, was a priority at that time.
What these setbacks mean is that vital communication and vital collaboration cannot move forward. Sometimes it's a small seed program, a small idea. We today do not know what will ultimately cure Parkinson's disease, so we need to support a lot of high-risk and low-risk programs, big collaborative efforts and small graduate student fellowship programs. We have to essentially come up with a multidisciplinary but also multidimensional approach to find the needle in the haystack that will ultimately change the game, as it did with the discovery of how cholesterol was being handled.